Is immunotherapy a viable option in treating mesothelioma?

Future Oncol. 2017 Aug;13(20):1747-1750. doi: 10.2217/fon-2017-0234. Epub 2017 Aug 4.
No abstract available

Keywords: CAR T cells; CTLA4; M2 macrophages; PD-1/PD-L1; dendritic cells; immunotherapy; mesothelioma; tumor micro-environment.

Publication types

  • Editorial

MeSH terms

  • Antigen Presentation / immunology
  • Antigens, Neoplasm / immunology
  • Cytotoxicity, Immunologic
  • Dendritic Cells / immunology
  • Dendritic Cells / metabolism
  • Humans
  • Immunotherapy* / methods
  • Lung Neoplasms / immunology*
  • Lung Neoplasms / therapy*
  • Lymphocytes, Tumor-Infiltrating / immunology
  • Lymphocytes, Tumor-Infiltrating / metabolism
  • Mesothelioma / immunology*
  • Mesothelioma / therapy*
  • Mesothelioma, Malignant
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism

Substances

  • Antigens, Neoplasm